The US scientists have found that a drug called lodamin, can be used to treat cancer. The drug was invented by a cancer researcher Dr. Judah Folkman, who died early this year. The drug which was developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers. The inventor of the drug, Folkman pioneered the idea of angiogenesis therapy, starving tumors by preventing them from growing blood supplies.
Writing in the journal Nature Biotechnology, Folkman’s colleagues say they developed a formulation that works as a pill, without side-effects. They have licensed it to SynDevRx, Inc, a privately held Cambridge, Massachusetts biotechnology company that has recruited several prominent cancer experts to its board. Tests on mice so far have proved that the drug is effective against some fatal diseases like breast cancer, ovarian cancer, prostate cancer, brain tumors.
The drug was known experimentally as TNP-470, and was originally isolated from a fungus called Aspergillus fumigatus fresenius. Donald Ingber had discovered the fungus by accident while trying to grow endothelial cells — the cells that line blood vessels.
But the drug affected the brain, causing depression, dizziness and other side-effects. It also did not stay in the body long and required constant infusions. The lab dropped it. Efforts to improve it did not work well. Then Benny and colleagues tried nanotechnology, attaching two “pom-pom“-shaped polymers to TNP-470, protecting it from stomach acid. In mice, the altered drug, now named lodamin, went straight to tumor cells and helped suppress melanoma and lung cancer, with no apparent side effects, researchers said.
Source: Reuters
Filed under Breast, Cancer, Health, Prostrate
Related?
Nanotechnology could make better food: scientistFebruary 14th, 2009 CHICAGO - Foods produced by nanotechnology are healthy and absorbed in the human body more efficiently, a Dutch scientist has said. 'The problem I always face is that people do not understand what we are doing with nanotechnology and food,' said Frans Kampers, one of the panelists gathered here for the American Association for the Advancement of Science annual meeting Saturday.
Schizophrenia drug may help fight cancerJune 3rd, 2009 MELBOURNE - A drug used to treat schizophrenia may help beat cancer, according to a leading Australian researcher. Sarah Ongeley, a University of New South Wales scientist, has reported the preliminary research on an anti-psychotic drug at this week's Australian Society for Medical Research conference in Sydney.
Tumour-targeting nanoparticles may spare patients from toxic chemotherapiesJune 17th, 2009 WASHINGTON - Scientists at the University of Central Florida say that they have created nanoparticles that may someday come to be used for targeting and destroying tumours, marking the end of toxic chemotherapies. J. Manuel Perez, an assistant professor at the university, has revealed that the nanoparticles designed by his team carry Taxol, one of the most widely used chemotherapeutic drugs.
Cancer growth obstructed by newly discovered drug: A miracle in medical science February 16th, 2009 Scientists are slowly progressing towards the summit of technology. We probably will be able to witness a world free from all deadly diseases in the near future.
Nano drugs can kill skin, breast cancer cellsDecember 26th, 2008 WASHINGTON - Nanoparticles 5,000 times as small as a human hair, carrying an experimental anti-cancer agent, kill human melanoma and drug-resistant breast cancer cells growing in lab cultures. The discovery could lead to the development of a new generation of anti-cancer drugs that are safer and more effective than conventional chemotherapy agents, researchers suggested.
Scientists create nanoparticle to fight drug addictionMarch 25th, 2009 WASHINGTON - Scientists at University at Buffalo (UB) have developed a nanoparticle that can silence a gene that triggers drug addiction. Boffins in UB's Institute for Lasers, Photonics and Biophotonics and UB's Department of Medicine have developed a stable nanoparticle that delivers short RNA molecules in the brain to "silence" or turn off a gene that plays a critical role in many kinds of drug addiction.
Experimental drug leads to remarkable recoveries in 2 prostate cancer patientsJune 20th, 2009 LONDON - Two patients with inoperable prostate cancer have made remarkable recoveries after being given only a single dose of an experimental drug, called ipilimumab. Rodger Nelson and Fructuoso Solano-Revuelta were diagnosed with advanced prostate cancer, and were part of a trial at the Mayo Clinic in Minnesota in the US that involved 108 patients, half of whom received the experimental drug.
Pfizer discontinues study on Sutent as a colon cancer drug, cites ineffectivenessJune 30th, 2009 Pfizer discontinues Sutent colon cancer studyNEW YORK — Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SOO-tent) as an initial treatment for colon cancer because the drug is not proving effective enough. Sutent is approved for advanced kidney cancer and gastrointestinal cancer.
